UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates 14 May 2024
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME 23 April 2024
